title: Heterogeneity of circulating epithelial tumour cells from individual patients with respect to expression profiles and clonal growth (sphere formation) in breast cancer.
abstract: BACKGROUND
  The detection of tumour cells circulating in the peripheral blood of patients with breast cancer is a sign that cells have been able to leave the primary tumour and survive in the circulation. However, in order to form metastases, they require additional properties such as the ability to adhere, self-renew, and grow. Here we present data that a variable fraction among the circulating tumour cells detected by the Maintrac(®) approach expresses mRNA of the stem cell gene NANOG and of the adhesion molecule vimentin and is capable of forming tumour spheres, a property ascribed to tumour-initiating cells (TICs).
  
  
  METHODS
  Between ten and 50 circulating epithelial antigen-positive cells detected by the Maintrac approach were selected randomly from each of 20 patients with breast cancer before and after surgery and were isolated using automated capillary aspiration and deposited individually onto slides for expression profiling. In addition, the circulating tumour cells were cultured without isolation among the white blood cells from 39 patients with breast cancer in different stages of disease using culture methods favouring growth of epithelial cells.
  
  
  RESULTS
  Although no epithelial cell adhesion molecule (EpCAM)-positive cells expressing stem cell genes or the adhesion molecule vimentin was detected before surgery, 10%-20% of the cells were found to be positive for mRNA of these genes after surgery. Tumour spheres from circulating cells of 39 patients with different stages of breast cancer were grown without previous isolation in a fraction increasing with the aggressivity of the tumour.
  
  
  CONCLUSIONS
  Here we show that among the peripherally circulating tumour cells, a variable fraction is able to express stem cell and adhesion properties and can be grown into tumour spheres, a property ascribed to cells capable of initiating tumours and metastases.
authors: Transfusion Center Bayreuth D-95448, Germany.
authors: M
authors: M
authors: Pizon
authors: D
authors: D
authors: Zimon
authors: S
authors: S
authors: Carl
authors: U
authors: U
authors: Pachmann
authors: K
authors: K
authors: Pachmann
authors: O
authors: O
authors: Camara
keywords: breast cancer; circulating epithelial tumour cells; tumour spheres
references: Ger Med Sci. 2005 Sep 13;3:Doc08
references: 19675725
references: Am J Pathol. 2002 Jun;160(6):1973-80
references: 12057902
references: Oncol Lett. 2012 Jan;3(1):50-54
references: 22740855
references: PLoS One. 2012;7(5):e33788
references: 22586443
references: Breast Cancer Res Treat. 1981;1(4):339-48
references: 6756512
references: J Clin Oncol. 1998 Aug;16(8):2672-85
references: 9704717
references: Cancer Res. 1984 Nov;44(11):4909-18
references: 6386145
references: Ann Oncol. 2007 Sep;18(9):1484-92
references: 17761704
references: J Cell Biol. 2011 Feb 7;192(3):373-82
references: 21300848
references: Cancer Res. 1977 Oct;37(10):3639-43
references: 908012
references: Clin Chem Lab Med. 2005;43(6):617-27
references: 16006258
references: Cancer Lett. 2013 Sep 10;338(1):69-73
references: 22445909
references: Clin Cancer Res. 2005 Aug 1;11(15):5657; author reply 5657-8
references: 16061886
references: World J Stem Cells. 2012 Mar 26;4(3):17-20
references: 22577494
references: Lancet Oncol. 2012 Jul;13(7):688-95
references: 22677156
references: Cancers (Basel). 2010 Mar 30;2(2):305-37
references: 24281072
references: J Natl Cancer Inst Monogr. 2001;(30):62-6
references: 11773294
references: Cancer Res. 2000 Aug 1;60(15):4033-6
references: 10945604
references: World J Surg Oncol. 2006 Sep 26;4:67
references: 17002789
references: Cancer. 2010 Jul 15;116(14):3330-7
references: 20564098
references: Mol Cancer Ther. 2013 Apr;12(4):491-8
references: 23445611
references: PLoS One. 2012;7(5):e37138
references: 22623986
references: Curr Opin Obstet Gynecol. 2013 Feb;25(1):66-73
references: 23262654
references: Front Endocrinol (Lausanne). 2012 Oct 23;3:125
references: 23109929
references: Cell Cycle. 2006 Aug;5(16):1756-9
references: 16880738
references: Clin Cancer Res. 2012 Feb 1;18(3):645-53
references: 22156560
references: Cancer Sci. 2012 Apr;103(4):626-31
references: 22212856
references: Blood. 1994 Nov 1;84(9):2930-9
references: 7524760
references: Differentiation. 2009 Jul;78(1):1-17
references: 19443100
references: J Cancer Res Clin Oncol. 2012 Apr;138(4):675-86
references: 22237455
references: J Immunol. 2005 Nov 15;175(10):6334-43
references: 16272285
references: J Clin Oncol. 2011 Apr 20;29(12):1508-11
references: 21422428
references: Clin Med Insights Oncol. 2012;6:199-203
references: 22619563
references: Am J Cancer Res. 2011;1(6):740-51
references: 22016824